Survival and Functional Outcomes in Paediatric Thalamic and Thalamopeduncular Low Grade Gliomas
Overview
Authors
Affiliations
Background: Childhood thalamopeduncular gliomas arise at the interface of the thalamus and cerebral peduncle. The optimal treatment is total resection but not at the cost of neurological function. We present long-term clinical and oncological outcomes of maximal safe resection.
Methods: Retrospective review of prospectively collected data: demography, symptomatology, imaging, extent of resection, surgical complications, histology, functional and oncological outcome.
Results: During 16-year period (2005-2020), 21 patients were treated at our institution. These were 13 girls and 8 boys (mean age 7.6 years). Presentation included progressive hemiparesis in 9 patients, raised intracranial pressure in 9 patients and cerebellar symptomatology in 3 patients. The tumour was confined to the thalamus in 6 cases. Extent of resection was judged on postoperative imaging as total (6), near-total (6) and less extensive (9). Surgical complications included progression of baseline neurological status in 6 patients, and 5 of these gradually improved to preoperative status. All tumours were classified as low-grade gliomas. Disease progression was observed in 9 patients (median progression-free survival 7.3 years). At last follow-up (median 6.1 years), all patients were alive, median Lansky score of 90. Seven patients were without evidence of disease, 6 had stable disease, 7 stable following progression and 1 had progressive disease managed expectantly.
Conclusion: Paediatric patients with low-grade thalamopeduncular gliomas have excellent long-term functional and oncological outcomes when gross total resection is not achievable. Surgery should aim at total resection; however, neurological function should not be endangered due to excellent chance for long-term survival.
Taborska J, Bubenikova A, Skalicky P, Taborsky J, Horvath D, Zapotocky M Brain Spine. 2025; 5:104183.
PMID: 39931644 PMC: 11808518. DOI: 10.1016/j.bas.2025.104183.
Roka K, Kersbergen K, Schouten-van Meeteren A, Avula S, Sehested A, Otth M Curr Oncol. 2024; 31(11):7330-7351.
PMID: 39590171 PMC: 11592938. DOI: 10.3390/curroncol31110541.
Surgical Treatment of Paediatric Thalamic Gliomas-Single-Centre Experience.
Krahulik D, Blazek F, Halaj M, Hrabalek L, Stepanova E, Pavelka Z Brain Sci. 2024; 14(2).
PMID: 38391716 PMC: 10886717. DOI: 10.3390/brainsci14020141.
Pan C, Li T, Zhang M, Wang Y, Xiao X, Zhang P J Neurosurg. 2023; 140(6):1527-1539.
PMID: 38134425 PMC: 10810682. DOI: 10.3171/2023.9.JNS23540.
DAmico A, Furlanis G, Baro V, Sartori L, Landi A, dAvella D J Clin Med. 2023; 12(17).
PMID: 37685588 PMC: 10488778. DOI: 10.3390/jcm12175521.